“The body is a complex dance between stimuli and response.”
Proventus.org.uk
Improving Life -
Our booklets of information are provided free to our members
All contents
© Copyright proventus.org.uk
UK Reg charity
No 1108986
Helpline
Tel 01233 334 879
E-
Website Maker
Serif
You are encouraged to report negative side effects of prescription drugs.
About the UCSF Centre
The Multiple Sclerosis Centre at the University of California serves the MS community of Northern California through a commitment to providing the highest standard of integrated patient care, innovative basic science and clinical research, and education. The UCSF MS centre cares for approximately 3,500 patients who suffer from MS and provides consultation for many more patients who geographically are unable to receive continuity of care in San Francisco. The MS Centre is committed to developing improved therapies for MS through clinical trials as well as basic science research oriented at understanding why patients develop MS and uncovering novel therapeutic strategies.
For more information about the UCSF MS Centre visit their website: www.ucsf.edu/msc/index.html
Accelerated Cure Project for Multiple Sclerosis,
http;//www.acceleratedcure.org is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its causes. Accelerated Cure Project believes this effort can be accelerated by organizing the research process and encouraging collaboration between research organizations and clinicians.
A "Cure Map" is currently being developed by Accelerated Cure Project to establish
what is known and what is not known about the causes of MS. From the Cure Map, Accelerated
Cure Project will facilitate research most likely to reveal the causes of MS in the
shortest time through a large-
For further information concerning Accelerated Cure Project or to make a corporate or individual donation.
Tel 781/487-
Source LDNers.org
Low Dose Naltrexone Feb 2007
Patient Advocates with Multiple Sclerosis Fund Clinical Trial of Promising Drug (LDN) that has Already Helped Thousands.
Summary: Over the last decade, anecdotal reports suggested that a very low dose of
an FDA-approved drug called naltrexone provides effective symptom relief for many
patients who suffer from Multiple Sclerosis.
Frustrated by the lack of scientific research, volunteers began raising money to fund a human clinical trial of Low Dose Naltrexone (LDN) for MS.
This effort culminated in awarding a $25,000 gift to the University of California, San Francisco Multiple Sclerosis Research Centre.
Dr Bernard Bihari, a Harvard trained neurologist in New York City, observed positive results in his patients using LDN for MS and other immune system disorders. His observations were published at www.ldninfo.org which is where an MS patient named Sammy Jo Wilkinson learned of it.
In February of 2004 I took my first 4.5 mg capsule recalls Wilkinson, and I have recovered without setbacks ever since. In 2005 she attended the 1st LDN Conference, and in conjunction with other patient advocates including the nonprofit Accelerated Cure Project for MS, formed a committee to raise funds to stimulate research for LDN treatment of MS.
In addition to Wilkinson, this committee also consisted of Robert Lester and Art Mellor. They set up a web site and received enthusiastic support from other patients who had benefited from LDN.
Contact:
Sammy Jo Wilkinson
Tel (USA) 425-
$25,000 had been raised, and word arrived that the UCSF Multiple Sclerosis Centre
was interested in conducting the first human trial in the US, to measure the impact
of LDN on MS. The funds were donated to UCSF, and a 3 month double-
